[Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study]

Gastroenterol Clin Biol. 2000 Dec;24(12):1234-5.
[Article in French]
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Drug Resistance, Microbial
  • Female
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / immunology
  • Hepatitis B, Chronic / pathology
  • Hepatitis B, Chronic / virology
  • Humans
  • Interferon-alpha / therapeutic use*
  • Lamivudine / therapeutic use*
  • Long-Term Care
  • Male
  • Middle Aged
  • Pilot Projects
  • Treatment Outcome
  • Vidarabine Phosphate / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Vidarabine Phosphate
  • Lamivudine